Who does it serve and what problem does it solve?
Cash-pay compounded GLP-1 online prescriptions, no insurance
Target Audience
US adults paying out of pocket for online weight loss (Club Compound patients)
How does it charge?
one-timeClub Compound site: tirzepatide 3-month plan $399–699, 6-month $899–1,099; semaglutide $399–1,149 (the $29.90–84.90/month in the input is the price of the IntakeQ software itself, not this site)
The above describes historical pricing. Check official website for current prices.
Where do users come from?
Almost no customer acquisition: direct 80.5%, email 14.7%, which is existing patients coming back to log in and fill out forms; social 2.9% from Facebook. Peak of 13,950 in August, 3,316 in September.
Channel share, initial acquisition, and growth drivers are distinct; correlation does not imply proven causation.
What remains to be verified?
The following are research questions, not established market opportunities.
- What do target users actually pay for? Is there direct user feedback or paid interview evidence?
- Are these historical prices still active today? What are the conversion, retention, and fulfillment costs?
- Is the "Other" channel still viable? What resources do indie devs need to test it?
- Whose needs are competitors failing to meet? Find specific evidence before deciding on your angle.